• SIS/TK 340/AG 1 ·
• SIS/TK 340/AG 2 ·
• SIS/TK 340/AG b ·
• SIS/TK 340/AG i ·

• AB Sandvik Materials Technology, SANDVIKEN
• Danderyds Sjukhus AB, STOCKHOLM
• Dentsply IH AB, Mölndal
• Etteplan Industry AB, Stockholm
• Forvalue AB, GÖTEBORG
• Gambro Lundia AB, LUND
• Karolinska Institutet, Stockholm
• Karolinska Universitetssjukhuset, HUDDINGE
• Läkemedelsverket, UPPSALA
• Lunds Universitet, LUND
• Maquet Critical Care AB, SOLNA
• Mölnlycke Health Care AB, GÖTEBORG
• Nobel Biocare AB, GÖTEBORG
• Q-Med A Galderma Division, UPPSALA
• Sahlgrenska universitetssjukhuset, MÖLNDAL
• St Jude Medical Systems AB, UPPSALA
• Swemac Innovation AB, LINKÖPING

• CEN/CLC/JWG AIMD, Active Implantable Medical Devices
• CEN/TC 206, Biological evaluation of medical devices
• CEN/TC 258, Clinical investigations
• CEN/TC 285, Non-active surgical implants
• CEN/TC 285/TF 1, Injectibles
• CEN/TC 285/WG 3, Cardiac and vascular implants
• CEN/TC 285/WG 4, Joint replacement and tools and accessories
• CEN/TC 285/WG 5, Osteosynthesis (Dormant)
• CEN/TC 285/WG 6, Mammary implants
• CEN/TC 316, Medical products utilizing cells, tissues and/or their derivatives
• ISO/TC 150, Implants for surgery
• ISO/TC 150/SC 2/WG 1, Cardiac valves
• ISO/TC 150/SC 2/WG 3, Vascular prostheses
• ISO/TC 150/SC 2/WG 4, Blood gas exchangers
• ISO/TC 150/SC 2/WG 5, Renal replacement, detoxification and apheresis
• ISO/TC 150/SC 4/WG 1, Mechanical testing of components
• ISO/TC 150/SC 5/WG 1, Osteosynthesis devices
• ISO/TC 150/SC 5/WG 2, Spinal devices
• ISO/TC 150/SC 6/JWG 1, Pacemakers
• ISO/TC 150/SC 6/WG 1, Fundamental standards
• ISO/TC 150/SC 6/WG 3, Cochlear implants
• ISO/TC 150/SC 6/WG 4, Implantable infusion pumps
• ISO/TC 150/SC 6/WG 5, Implantable neurostimulators
• ISO/TC 150/SC 6/WG 6, Circulatory support devices
• ISO/TC 150/WG 08, Breast implants
• ISO/TC 150/WG 10, Data on implanted and retrieved devices
• ISO/TC 150/WG 11, Tissue engineered implants
• ISO/TC 150/WG 7, Fundamental standards
• ISO/TC 150/WG 8, Breast implants
• ISO/TC 170, Surgical instruments
• ISO/TC 194, Biological evalaution of medical devices
• ISO/TC 194/SC 1/WG 1, Risk assessment, terminology and global aspects
• ISO/TC 194/SC 1/WG 2, Sourcing controls, collection and handling
• ISO/TC 194/SC 1/WG 3, Elimination and /or inactivation of viruses and TSE agents
• ISO/TC 194/WG 1, Systemic approach to biological evaluation and terminology
• ISO/TC 194/WG 10, Implantation
• ISO/TC 194/WG 11, Allowable limits for leachable substances
• ISO/TC 194/WG 12, Sample preparation and reference materials
• ISO/TC 194/WG 13, Toxicokinetic study
• ISO/TC 194/WG 14, Material characterisation
• ISO/TC 194/WG 15, Strategic approach to biological evaluation of medical devices
• ISO/TC 194/WG 2, Degradation aspects related to biological testing
• ISO/TC 194/WG 3, Animal protection aspects
• ISO/TC 194/WG 4, Clinical investigations of medical devices in humans
• ISO/TC 194/WG 5, Cytotoxicity
• ISO/TC 194/WG 6, Mutagenicity, cancerogenicity, reproductive toxicity
• ISO/TC 194/WG 7, Systemic toxicity
• ISO/TC 194/WG 8, Irritation, sensitization
• ISO/TC 194/WG 9, Effects on blood

The work is directed and funded by the organizations that participate in the committee. The fee charged reflects the mode and scope of the project, and number of participants.